| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Feel better with Beme. Get life skills, personal coaching, and support. Created for teens, Beme is a place where you can feel safe during good times and tough times. Learn new ways to take care of yourself and make every day better.
Forward is a startup redesigning the way we deliver healthcare using all the technologies healthcare has neglected: sensors, mobile, and AI.
IceWarp, Inc. is a software company located in Springfield, VA developing IceWarp Mail Server.
Originate is a digital product development and venture firm. We design, build, operate, and invest in transformational software products. Our designers, developers, and product strategists design and build modern mobile, web, and data-driven software in iOS, Android, Ruby, Scala, Node.js, Javascript, and other scalable technologies. To fully align partners and employees, Originate passes through 20% of the upside it earns in each partnership to the employees that contributed to the success. Founded in 2007, Originate has nine global offices in San Francisco, Silicon Valley, Los Angeles, Orange County, Las Vegas, New York, Boston, Stockholm, and Hangzhou, China.